Platinum Investment Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-21,157
| Closed | -$3.43M | – | 155 |
|
2021
Q2 | $3.43M | Sell |
21,157
-16,068
| -43% | -$2.6M | 0.08% | 76 |
|
2021
Q1 | $2.99M | Sell |
37,225
-7,738
| -17% | -$621K | 0.07% | 73 |
|
2020
Q4 | $2.45M | Sell |
44,963
-20,068
| -31% | -$1.09M | 0.06% | 84 |
|
2020
Q3 | $1.29M | Sell |
65,031
-18,706
| -22% | -$372K | 0.03% | 100 |
|
2020
Q2 | $1.76M | Hold |
83,737
| – | – | 0.04% | 91 |
|
2020
Q1 | $1.02M | Buy |
83,737
+17,567
| +27% | +$215K | 0.03% | 99 |
|
2019
Q4 | $971K | Hold |
66,170
| – | – | 0.02% | 88 |
|
2019
Q3 | $883K | Sell |
66,170
-54,684
| -45% | -$730K | 0.02% | 85 |
|
2019
Q2 | $1.98M | Hold |
120,854
| – | – | 0.05% | 59 |
|
2019
Q1 | $2.06M | Buy |
120,854
+13,913
| +13% | +$238K | 0.05% | 63 |
|
2018
Q4 | $1.46M | Buy |
106,941
+51,941
| +94% | +$709K | 0.05% | 62 |
|
2018
Q3 | $1.57M | Hold |
55,000
| – | – | 0.04% | 62 |
|
2018
Q2 | $1.51M | Hold |
55,000
| – | – | 0.04% | 61 |
|
2018
Q1 | $1.16M | Buy |
+55,000
| New | +$1.16M | 0.03% | 67 |
|